Literature DB >> 669815

Contrast of Glycogenesis and protein synthesis in monkey kidney cells and HeLa cells infected with Chlamydia trachomatis lymphogranuloma venereum.

D A Weigent, H M Jenkin.   

Abstract

Glycogen metabolism of monkey kidney (LLC-MK-2) cells and HeLa 229 cells infected with a Chlamydia trachomatis lymphogranuloma venereum 440 L (LGV) was studied. The growth cycle of LGV in both host cells was similar; however, a greater number of infectious organism developed intracellularly and were released into the medium during LGV infection of HeLa 229 cells than MK-2 cells. A rapid infection accompanied by a high rate of glycogen synthesis and a short period of accumulation was found in GeLa 229 cells infected with LGV. LGV infected MK-2 cells started to accumulate glycogen about the same time as HeLa 229 cells; however, the rate of glycogen synthesis was lower and the period of accumulation was longer. The LGV agent grew in cycloheximide-treated cells in the absence of host cell protein synthesis. Protein synthesis associated with LGV throughout the developmental cycle was similar in both cell types and could be abolished by chloramphenicol. The continued synthesis of glycogen in the presence of cycloheximide suggested that the synthesis of glycogen was directed by the organism in both MK-2 cells and HeLa 229 cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 669815      PMCID: PMC421905          DOI: 10.1128/iai.20.3.632-639.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  EGG INFECTIVITY ASSAY OF TRACHOMA VIRUS.

Authors:  S P WANG; J T GRAYSTON
Journal:  Proc Soc Exp Biol Med       Date:  1964-03

2.  THE OCCURRENCE OF ADENOSINE DIPHOSPHATE GLUCOSE: GLYCOGEN TRANSGLUCOSYLASE IN BACTERIA.

Authors:  E GREENBERG; J PREISS
Journal:  J Biol Chem       Date:  1964-12       Impact factor: 5.157

3.  OCCURENCE OF GLYCOGEN IN INCLUSIONS OF THE PSITTACOSIS-LYMPHOGRANULOMA VENEREUM-TRACHOMA AGENTS.

Authors:  F B GORDON; A L QUAN
Journal:  J Infect Dis       Date:  1965-04       Impact factor: 5.226

4.  Correlation between morphological and biochemical changes and the appearance of infectivity in FL cell cultures infected with trachoma agent.

Authors:  H BERNKOPF; P MASHIAH; Y BECKER
Journal:  Ann N Y Acad Sci       Date:  1962-03-05       Impact factor: 5.691

5.  The titration of trachoma and inclusion blennorrhoea viruses in cell cultures.

Authors:  G FURNESS; D M GRAHAM; P REEVE
Journal:  J Gen Microbiol       Date:  1960-12

6.  The submerged culture of mammalian cells; the spinner culture.

Authors:  W F McLIMANS; E V DAVIS; F L GLOVER; G W RAKE
Journal:  J Immunol       Date:  1957-11       Impact factor: 5.422

7.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

8.  Glycogen metabolism in Chlamydia-infected HeLa-cells.

Authors:  V S Fan; H M Jenkin
Journal:  J Bacteriol       Date:  1970-10       Impact factor: 3.490

9.  CYCLOHEXIMIDE: ASPECTS OF INHIBITION OF PROTEIN SYNTHESIS IN MAMMALIAN CELLS.

Authors:  H L ENNIS; M LUBIN
Journal:  Science       Date:  1964-12-11       Impact factor: 47.728

10.  Separation of protein synthesis in meningopneumonitisgent from that in L cells by differential susceptibility to cycloheximide.

Authors:  J J Alexander
Journal:  J Bacteriol       Date:  1968-02       Impact factor: 3.490

View more
  3 in total

Review 1.  Interaction of chlamydiae and host cells in vitro.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1991-03

2.  Glycogen assay for diagnosis of female genital Chlamydia trachomatis infection.

Authors:  Y Chun; Z D Yin
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

3.  Cytochemical localization of glycogen in Chlamydia trachomatis inclusions.

Authors:  M L Chiappino; C Dawson; J Schachter; B A Nichols
Journal:  J Bacteriol       Date:  1995-09       Impact factor: 3.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.